The Quality of Rare Disease Registries: Evaluation and Characterization
Public Health Genomics · 2016 · 19 (2) · 108-115
DOI: 10.1159/000444476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Public Health Genomics, online erschienen am 22.03.2016. Verfasst von Alessio Coi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Physiology, National Research Council, Pisa, Italy. Hauptthemen laut MEDLINE: Rare Diseases. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Background
The focus on the quality of the procedures for data collection, storing, and analysis in the definition and implementation of a rare disease registry (RDR) is the basis for developing a valid and long-term sustainable tool. The aim of this study was to provide useful information for characterizing a quality profile for RDRs using an analytical approach applied to RDRs participating in the European Platform for Rare Disease Registries 2011-2014 (EPIRARE) survey.
Methods
An indicator of quality was defined by choosing a small set of quality-related variables derived from the survey. The random forest method was used to identify the variables best defining a quality profile for RDRs. Fisher's exact test was employed to assess the association with the indicator of quality, and the Cochran-Armitage test was used to check the presence of a linear trend along different levels of quality.
Results
The set of variables found to characterize high-quality RDRs focused on ethical and legal issues, governance, communication of activities and results, established procedures to regulate access to data and security, and established plans to ensure long-term sustainability.
Conclusions
The quality of RDRs is usually associated with a good oversight and governance mechanism and with durable funding. The results suggest that RDRs would benefit from support in management, information technology, epidemiology, and statistics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of Clinical Physiology, National Research Council, Pisa, Italy.
Zitieren
APA
Coi, A., Santoro, M., Villaverde-Hueso, A., Lipucci Di Paola, M., Gainotti, S., Taruscio, D., Posada de la Paz, M., & Bianchi, F. (2016). The Quality of Rare Disease Registries: Evaluation and Characterization. Public Health Genomics, 19(2), 108-115. https://doi.org/10.1159/000444476
Vancouver
Coi A, Santoro M, Villaverde-Hueso A, Lipucci Di Paola M, Gainotti S, Taruscio D, et al. The Quality of Rare Disease Registries: Evaluation and Characterization. Public Health Genomics. 2016;19(2):108-115. doi:10.1159/000444476
BibTeX
@article{Coi2016,
author = {Coi, Alessio and Santoro, Michele and Villaverde-Hueso, Ana and Lipucci Di Paola, Michele and Gainotti, Sabina and Taruscio, Domenica and Posada de la Paz, Manuel and Bianchi, Fabrizio},
title = {The Quality of Rare Disease Registries: Evaluation and Characterization},
journal = {Public Health Genomics},
year = {2016},
volume = {19},
number = {2},
pages = {108--115},
doi = {10.1159/000444476}
}
EUVIMED